Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Dinakar, H. S. Articles by Mauro, S. Search for Related Content PubMed Citation Articles by Dinakar, H. S. Articles by Mauro, S. Chronically Mentally Ill Patients Hospitals, Hospital Treatment Atypical Neuroleptics Schizophrenia Spectrum Disorders

Efficacy of Olanzapine and Risperidone for Treatment-Refractory Schizophrenia Among Long-Stay State Hospital Patients

The authors studied the efficacy of olanzapine and risperidone among patients with treatment-refractory schizophrenia who had been hospitalized for more than five years and who were not suitable candidates for a clozapine trial. The patients were systematically reassessed and were given olanzapine or risperidone as part of a "second-chance program." The patients in both groups showed significant improvement in scores on the 18-item Brief Psychiatric Rating Scale after three months. Forty-four percent of the patients in the olanzapine group and 43 percent of those in the risperidone group were discharged to supervised residences on the basis of their clinical improvement. There is value in reassessing long-stay patients who have treatment-refractory schizophrenia and giving them systematic trials with new medications that become available.

This article has been cited by other articles:

				J. H. Jenkins, M. E. Strauss, E. A. Carpenter, D. Miller, J. Floersch, and M. Sajatovic Subjective Experience of Recovery from Schizophrenia-Related Disorders and Atypical Antipsychotics International Journal of Social Psychiatry, September 1, 2005; 51(3): 211 - 227. [Abstract] [PDF]

				G. G Liu, S. X Sun, D. B Christensen, and X. Luo Cost Comparisons of Olanzapine and Risperidone in Treating Schizophrenia Ann. Pharmacother., January 1, 2004; 38(1): 134 - 141. [Abstract] [Full Text] [PDF]

				L. H. Beebe Health Promotion in Persons with Schizophrenia: Atypical Medications Journal of the American Psychiatric Nurses Association, August 1, 2003; 9(4): 115 - 122. [Abstract] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2002 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us